Hansoh Pharmaceutical Group Co Ltd has re-filed its application to conduct an initial public offering (IPO) in Hong Kong that could fetch the Chinese drug-maker at least $500 million, people with direct knowledge of the matter said on Friday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
